Skip to main content
CVE-2026-86383VulnerabilityPublished

Dell PowerProtect Data Domain, Feature Release versions 7.7.1.0 through 8.8, LTS2025 release versions 8.3.1.0 through

Source GCVE Database

0
Authoritative record:CVE-2026-86383· Medium 6.8

Not known to be exploited · CVSS 6.8 Medium · fixed in 8.9.0.0 or later : update PowerProtect Data Domain when convenient.

Data as of 28 Oct 2026, 14:30 UTC

CVSS 3.1 base score
6.8Medium
How severe the flaw is on the 0–10 CVSS scale.
Patch
Available – fixed in 8.9.0.0 or later, 8.6.1.30 or later, 8.3.1.50 or later
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 28 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade PowerProtect Data Domain to 8.9.0.0 or later, 8.6.1.30 or later or 8.3.1.50 or later.

Affected software

ProductAffectedFixed in
DellPowerProtect Data DomainAffected
  • =0
Fixed in
  • 8.9.0.0 or later
  • 8.6.1.30 or later
  • 8.3.1.50 or later

AI-suggested

If you cannot patch yet, restrict remote access to trusted users with high privileges and monitor for unusual activity related to path traversal attempts.

Description

Dell PowerProtect Data Domain versions 7.7.1.0 through 8.8 (Feature Release), 8.3.1.0 through 8.3.1.40 (LTS2025), and 8.6.1.0 through 8.6.1.20 (LTS2026) contain a path traversal vulnerability. This flaw allows a high privileged attacker with remote access to potentially disclose sensitive information. The vulnerability is identified as CWE-22 and has a CVSS 3.1 base score of 6.8, indicating medium severity.

References

Community reviews

Loading reviews…